Status:
UNKNOWN
Investigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic Technologies
Lead Sponsor:
Soroka University Medical Center
Collaborating Sponsors:
Ben-Gurion University of the Negev
Conditions:
Brucellosis
Zoonotic Disease
Eligibility:
All Genders
Brief Summary
Zoonosis including brucellosis and rickettsial infections are a major contributor to infectious morbidity in southern Israel. The Bedouins, a nomadic tribal population residing in the Negev area are n...
Detailed Description
This study aims to apply advanced technologies for the investigation of febrile illness in the Bedouin population, in order to improve laboratory diagnosis in terms of rapidity and sensitivity and to ...
Eligibility Criteria
Inclusion
- \- Willing and able to provide informed consent (in case of children the legal guardian is willing to provide informed consent)
- All patients of Bedouin origin arriving at the SUMC ED during the study period with:
- fever \>38.1 (either documented or reported), without an apparent infection source plus one of the following signs or symptoms
- Headache
- Rash
- Arthralgia, arthritis
- Weakness
- Myalgia
- epididymo-orchitis
- leukopenia, thrombocytopenia, elevated liver enzymes
- other findings suggestive of zoonotic infection
- Patients who were diagnosed with a zoonotic infection prior to or during hospital stay.
Exclusion
- \- Patients with an established source of infection other than zoonosis (such as urinary tract infection, pneumonia, upper respiratory tract infection), or a non-infectious cause of fever (malignancy, rheumatic disease etc.).
- Pregnant women
- Children weighing less than 6.5 kg
Key Trial Info
Start Date :
May 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04717622
Start Date
May 23 2021
End Date
March 1 2024
Last Update
November 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Soroka University Medical Center
Beersheba, Israel